Since 2005, triple-negative breast cancer (TNBC) identifies a specific subtype of breast cancer, characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [3]. The gene discussed is PGR; the disease is breast cancer.